Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04551560 · ClinicalTrials.gov registry record · NA
Stress and Congestive Heart Failure
A NA study of Congestive Heart Failure, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 2
- Study locations
NCT04551560: Recruiting NA study of Congestive Heart Failure, sponsored by Yale University.
NCT04551560 is a NA study of Congestive Heart Failure that is actively recruiting participants, run by Yale University. The registered enrollment target is 112 participants, below the 328-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (66% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04551560, a NA study of Congestive Heart Failure, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to investigate whether acute stress can precipitate congestive heart failure (CHF) exacerbation in patients with CHF.
Primary Outcome
Pulmonary artery pressure as measured by an implanted monitor: Pulmonary artery pressure will be compared between times of stress and calm, in both the laboratory and real-life setting.
Conditions Studied
Interventions
- OTHER Mental Stress
Study Locations (2)
Connecticut
- St. Francis Hospital - Hartford
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2020-12-02 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What NCT04551560 shows while recruiting
NCT04551560 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 328-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Mental Stress is the first listed.
NCT04551560 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT04551560 about?
NCT04551560 is a clinical study titled "Stress and Congestive Heart Failure". The purpose of this study is to investigate whether acute stress can precipitate congestive heart failure (CHF) exacerbation in patients with CHF.
What is the current status of trial NCT04551560?
This trial is currently recruiting. It is a NA study. The enrollment target is 112 participants. The study started on 2020-12-02. Estimated completion is 2026-04-30.
What conditions does trial NCT04551560 study?
This clinical trial studies the following conditions: Congestive Heart Failure.
What interventions are being tested in trial NCT04551560?
The interventions under investigation include: Mental Stress (OTHER).
Who is sponsoring clinical trial NCT04551560?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04551560 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04551560's enrollment target sits among peer trials
112 28th of 51 higher than 24 of 51 other Congestive Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congestive Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Care Transitions App for Patients With Multiple Chronic Conditions
RECRUITING · NA
-
SyncAV Post-Market Trial
ACTIVE NOT RECRUITING · NA
-
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
ACTIVE NOT RECRUITING · NA
-
Congestive Heart Failure Pilot Study Utilizing Wireless Home Scale and Daily Symptom Monitoring
COMPLETED · NA
-
Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
- NCT05157620 · 112 participants · NA
Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI